COVID-19 could be leading to an epidemic of

clinical depression

In the first month of restrictions, clinically-significant depressive and generalised anxiety symptoms, thoughts of being better off dead or of self-harm, and irritability were at least double those in non-COVID affected populations. In addition, one in four had mild to moderate symptoms. The most vulnerable people had lost jobs, lived alone or in poorly-resourced areas, were providing care to dependent family members, were members of marginalised minorities, women, or young.

Care is needed to understand the nature and respond to the very high prevalence of these problems.

Depression, and thoughts of being better off dead, are most likely to occur when people feel trapped, humiliated, and powerless^17-19 and have experienced loss.  Disenfranchised^20,21 grief describes experiences of loss which might not be recognised, by self or others and lead to disbelief, yearning, uncertainty, and sadness. Everyone experienced some loss of liberty, autonomy, and agency as everyday activities were restricted, some precluded. Privacy was lost with the close scrutiny of adherence to health behaviours, but paradoxically, enforced through required isolation. Many people lost events of lifetime significance: weddings, end-of-life support for loved ones, or milestone celebrations. Occupational identity and capacity to earn an income are fundamental to adult individuality, sense of purpose, and autonomy. Loss of these is profound and associated directly with demoralisation and depression. Unrecognised losses do not attract increased social support or rituals that accompany bereavement. They can induce powerlessness, rather than the problem-solving that is needed to reduce psychological pain. Anxiety is elevated in situations of threat or invisible danger and uncertainty, in particular where definite parameters about duration and evidence underpinning specific restrictions could not be provided.

Walker Series Bright Mind uses herbal medicines to relieve the symptoms of fatigue and is formulated with adaptogen medicines to help the body adapt to and reduce the symptoms of stress to support a healthy mood balance. Bright Mind helps enhance and improve cognitive performance while supporting brain functions including learning and information processing.  Formulated to support memory functions including mental recall, Bright Mind includes Ayurvedic medicines known to help enhance brain health and support mental clarity.

• Bacopa monnieri has been shown to improve cognition, by means of reducing anxiety. It is also reliable for improving memory formation
• Rhodiola can improve cognitive functioning in persons who experience a reduction in fatigue
• Soy phosphatidylserine can improve the memory functions of the elderly with memory complaints
• Nicotinamide and Nicotinic acid are precursor ingredients which the body can convert into the CoEnzyme NAD (Nicotinamide adenine dinucleotide)
• Panax ginseng is effective for mood, immunity, and cognition
• Choline bitartrate is used for its cognitive boosting properties
• NadVita Walker Series Bright Mind is formulated to help to maintain and support energy levels, general health, and wellbeing